These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11593149)

  • 41. No proof of cross-reactivity between celecoxib and antibiotic sulfonamides.
    Smith WB; Mullins RJ
    Intern Med J; 2007 May; 37(5):347-8. PubMed ID: 17504291
    [No Abstract]   [Full Text] [Related]  

  • 42. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
    Varas-Lorenzo C; Maguire A; Castellsague J; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):366-76. PubMed ID: 16897817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
    Goldstein JL; Zhao SZ; Burke TA; Palmer R; von Allmen H; Henderson SC
    Am J Gastroenterol; 2003 Dec; 98(12):2627-34. PubMed ID: 14687808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Adverse cutaneous reaction to celecoxib: 6 cases].
    Murr D; Bocquet H; Lelouet H; Fischer RM; Revuz J; Cosnes A
    Ann Dermatol Venereol; 2003 May; 130(5):519-21. PubMed ID: 12843828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Could it be a drug eruption?
    Bruce F
    Aust Fam Physician; 1997 Jun; 26(6):689-95. PubMed ID: 9197056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Celecoxib-induced methemoglobinemia.
    Kaushik P; Zuckerman SJ; Campo NJ; Banda VR; Hayes SD; Kaushik R
    Ann Pharmacother; 2004 Oct; 38(10):1635-8. PubMed ID: 15328400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Celecoxib-induced upper gastrointestinal hemorrhage and ulceration.
    Crawford AS; White JG
    South Med J; 2002 Dec; 95(12):1444-6. PubMed ID: 12597315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
    White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
    Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Symptomatic therapy of arthrosis and rheumatoid arthritis. Who will benefit from Coxib?].
    MMW Fortschr Med; 2002 Apr; 144(14):53. PubMed ID: 12014284
    [No Abstract]   [Full Text] [Related]  

  • 50. Balancing the risks and benefits of celecoxib.
    Caldwell B; Beasley R; Weatherall M; Metcalfe S
    Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
    [No Abstract]   [Full Text] [Related]  

  • 51. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy.
    Goldstein JL; Eisen GM; Lewis B; Gralnek IM; Aisenberg J; Bhadra P; Berger MF
    Aliment Pharmacol Ther; 2007 May; 25(10):1211-22. PubMed ID: 17451567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug induced fatal anaphylactic shock in Denmark 1968-1990].
    Lenler-Petersen P; Hansen D; Andersen M; Sørensen HT; Bille H
    Ugeskr Laeger; 1996 Jun; 158(23):3316-8. PubMed ID: 8686061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
    Zembowicz A; Mastalerz L; Setkowicz M; Radziszewski W; Szczeklik A
    Arch Dermatol; 2003 Dec; 139(12):1577-82. PubMed ID: 14676074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A; Krahn M; Naglie G
    Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Celecoxib].
    Babić-Naglić D
    Reumatizam; 2001; 48(2):27-8. PubMed ID: 12476745
    [No Abstract]   [Full Text] [Related]  

  • 57. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia.
    Rattray B; Nugent DJ; Young G
    Haemophilia; 2006 Sep; 12(5):514-7. PubMed ID: 16919082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contact dermatitis from 3 different allergens in Solaraze gel.
    Kleyn CE; Bharati A; King CM
    Contact Dermatitis; 2004 Oct; 51(4):215-6. PubMed ID: 15500677
    [No Abstract]   [Full Text] [Related]  

  • 59. Fixed drug eruption to nimesulide: an exuberant presentation confirmed by patch testing.
    Marques LP; Villarinho ALCF; Melo MDGM; Torre MGS
    An Bras Dermatol; 2018 Jun; 93(3):470-472. PubMed ID: 29924254
    [No Abstract]   [Full Text] [Related]  

  • 60. Metabolites and allergic drug reactions.
    Merk HF; Baron J; Kawakubo Y; Hertl M; Jugert F
    Clin Exp Allergy; 1998 Sep; 28 Suppl 4():21-4. PubMed ID: 9761025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.